It can take approximately 14 years and cost around $2 billion dollars for new cancer therapies and interventions to reach clinical settings, according to the National Institutes of Health. Failure rates for new cancer therapies and interventions approach 95 percent. Even when cancer therapies and interventions are shown to be effective in clinical trials, many years can go by before they become available to patients.
The Cancer Research Collaboration facilitates partnerships among researchers and clinicians to improve delivery of effective cancer therapies and interventions to patients. While these therapies may not provide benefit or ultimately succeed on their own, scientific data gathered during clinical trials adds to our knowledge of cancer.
Barriers to cancer therapies and interventions under investigation
Researchers often encounter common barriers when investigating new therapies and interventions. These include:
- Problems recruiting and maintaining a team of qualified clinical investigators.
- Costs associated with research.
- Difficulty recruiting and retaining patients in clinical research studies.
- Poorly constructed study designs.
- Regulatory hurdles.
In order to overcome these challenges, researchers require access to tools and resources that can expedite and simplify lengthy processes while also accounting for patient safety.
How Cancer Research Collaboration Helps
By reducing the burden on researchers, we can aid in the development of effective cancer therapies and interventions that reach patients in a timely manner. Cancer Research Collaboration is committed to bridging the gap between scientists and clinical investigators to ultimately help patients fighting cancer.
Cancer Research Collaboration can assist researchers in the following ways:
- Providing funds to researchers to implement research projects and programs in community settings.
- Offering access to teams of clinicians with experience specific to various kinds of research and access to staff trained for quality data collection.
- Identifying patients, by working with our partners, who are qualified candidates for research projects, and supporting them throughout their treatment to improve patient retention.